These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27999295)

  • 1. Special Issue: "Molecules against Alzheimer".
    Decker M; Muñoz-Torrero D
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27999295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease.
    Weinreb O; Amit T; Bar-Am O; Youdim MB
    Br J Pharmacol; 2016 Jul; 173(13):2080-94. PubMed ID: 26332830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases.
    Mathew B; Parambi DGT; Mathew GE; Uddin MS; Inasu ST; Kim H; Marathakam A; Unnikrishnan MK; Carradori S
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900177. PubMed ID: 31478569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present).
    Wang N; Qiu P; Cui W; Yan X; Zhang B; He S
    Curr Med Chem; 2019; 26(30):5684-5710. PubMed ID: 30501591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective Potential of Novel Multi-Targeted Isoalloxazine Derivatives in Rodent Models of Alzheimer's Disease Through Activation of Canonical Wnt/β-Catenin Signalling Pathway.
    Machhi J; Sinha A; Patel P; Kanhed AM; Upadhyay P; Tripathi A; Parikh ZS; Chruvattil R; Pillai PP; Gupta S; Patel K; Giridhar R; Yadav MR
    Neurotox Res; 2016 May; 29(4):495-513. PubMed ID: 26797524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's Drug Discovery Maze: A Snap View of the Past Decade's Diverse Pharmacological Targets for the Disorder.
    Sikazwe D; Yendapally R; Ramsinghani S; Khan M
    Mini Rev Med Chem; 2017; 17(3):305-318. PubMed ID: 27549097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease.
    Wang T; Liu XH; Guan J; Ge S; Wu MB; Lin JP; Yang LR
    Eur J Med Chem; 2019 May; 169():200-223. PubMed ID: 30884327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease.
    Zheng H; Amit T; Bar-Am O; Fridkin M; Youdim MB; Mandel SA
    J Alzheimers Dis; 2012; 30(1):1-16. PubMed ID: 22387411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors.
    Reis J; Cagide F; Valencia ME; Teixeira J; Bagetta D; Pérez C; Uriarte E; Oliveira PJ; Ortuso F; Alcaro S; Rodríguez-Franco MI; Borges F
    Eur J Med Chem; 2018 Oct; 158():781-800. PubMed ID: 30245401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching for Multi-Targeting Neurotherapeutics against Alzheimer's: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif.
    Pisani L; Farina R; Soto-Otero R; Denora N; Mangiatordi GF; Nicolotti O; Mendez-Alvarez E; Altomare CD; Catto M; Carotti A
    Molecules; 2016 Mar; 21(3):362. PubMed ID: 26999091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease.
    García-Font N; Hayour H; Belfaitah A; Pedraz J; Moraleda I; Iriepa I; Bouraiou A; Chioua M; Marco-Contelles J; Oset-Gasque MJ
    Eur J Med Chem; 2016 Aug; 118():178-92. PubMed ID: 27128182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease.
    Jalili-Baleh L; Babaei E; Abdpour S; Nasir Abbas Bukhari S; Foroumadi A; Ramazani A; Sharifzadeh M; Abdollahi M; Khoobi M
    Eur J Med Chem; 2018 May; 152():570-589. PubMed ID: 29763806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines.
    Romero A; Marco-Contelles J
    Curr Top Med Chem; 2017; 17(31):3328-3335. PubMed ID: 29332586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease.
    Chen Z; Digiacomo M; Tu Y; Gu Q; Wang S; Yang X; Chu J; Chen Q; Han Y; Chen J; Nesi G; Sestito S; Macchia M; Rapposelli S; Pi R
    Eur J Med Chem; 2017 Jan; 125():784-792. PubMed ID: 27736684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease.
    Li Q; He S; Chen Y; Feng F; Qu W; Sun H
    Eur J Med Chem; 2018 Oct; 158():463-477. PubMed ID: 30243151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.
    Maqbool M; Manral A; Jameel E; Kumar J; Saini V; Shandilya A; Tiwari M; Hoda N; Jayaram B
    Bioorg Med Chem; 2016 Jun; 24(12):2777-88. PubMed ID: 27157006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's Disease: A Systemic Review of Substantial Therapeutic Targets and the Leading Multi-functional Molecules.
    Umar T; Hoda N
    Curr Top Med Chem; 2017; 17(31):3370-3389. PubMed ID: 29332579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Multitarget Hybrid Compounds for the Treatment of Alzheimer's Disease.
    Michalska P; Buendia I; Del Barrio L; Leon R
    Curr Top Med Chem; 2017; 17(9):1027-1043. PubMed ID: 27697052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current progresses of novel natural products and their derivatives/ analogs as anti-Alzheimer candidates: an update.
    Fang L; Gou S; Fang X; Cheng L; Fleck C
    Mini Rev Med Chem; 2013 May; 13(6):870-87. PubMed ID: 23305400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor.
    Weinreb O; Amit T; Bar-Am O; Youdim MB
    Int Rev Neurobiol; 2011; 100():191-215. PubMed ID: 21971009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.